Kakodkar et al. [35] |
LAR with TME (CAA) |
Anorectal manometry |
Frequency: 3.3 ± 0.17 |
Wexner continence questionnaire |
MBP (cmH2O): 37.7 ± 0.41 |
MSP (cmH2O): 76.6 ± 0.54 |
MTV (mL): 146.3 ± 4.06 |
Compliance (mL/cmH2O): 3.83 ± 0.27 |
RAIR – absent in half |
Wexner score: 4.37 ± 0.2 |
Akagi et al. [36] |
ISR |
Anorectal manometry |
Frequency: 5.1 (1–20) |
Wexner continence questionnaire |
MBP (cmH2O): 41 (4–84) |
MSP (cmH2O): 178 (20–346) |
Wexner score: 7.2 (1–20) |
Patient satisfaction (%) |
-Very low 8.8 |
-Medium 19.3 |
-Perfect 71.9 |
Dulskas and Samalavicius [37] |
LAR with TME |
Anorectal manometry |
Frequency: 3.3 ± 0.17 |
Wexner continence questionnaire |
MBP (cmH2O): 43 ± 5.7 |
MSP (cmH2O): 100 ± 8.9 |
MTV (mL): 140 ± 8.2 |
Wexner score: 6.3 (mean score) |
Shibata et al. [38] |
LAR with TME (CAA and intraoperative radiation) |
MSKCC Sphincter Function Scale |
More than one-half of the patients treated by sphincter preservation, EBRT, IORT, and chemotherapy had an unfavorable functional outcome. |
-EORTC QLQ-C30 |
Emmertsen et al. [10] |
LAR |
LARS score |
Higher risk of major LARS with neoadjuvant therapy af- ter TME and with temporary diverting stoma |
-TME vs. PME |
European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 |
LARS score has high sensitivity and specificity for iden- tifying patients with major bowel dysfunction causing impairment of QoL |
-Neoadjuvant vs. no Neoadjuvant |
Juul et al. [39] |
LAR (no stoma) |
LARS score |
Patients with major LARS fare substantially worse in 7 of the 8 EORTC QLQ-C30 compared with patients with no/minor LARS. |
EORTC QLQ-C30 |
Qin et al. [40] |
LAR |
LARS score |
nCRT had a higher risk of developing major LARS than nCT alone |
-nCRT vs nCT |
Postoperative pelvic MRI |